Elevance Health has paid over $342 million to the Centers for Medicare & Medicaid Services (CMS) to settle allegations that it overcharged Medicare Advantage, according to court filings and official company statements. The payment represents a significant move by CMS to hold private health plans accountable for billing practices within the federal healthcare program.
What Happened
On May 27, Elevance Health, a major Medicare Advantage insurer covering approximately two million beneficiaries, transferred $342,209,085.30 to CMS as a “remittance of the total overpayment amount,” court records reveal. This payment followed a CMS enforcement action announced in February 2023, during which the agency threatened to stop Elevance from enrolling new members due to what was described as “substantial and persistent noncompliance” with federal billing regulations. Those regulations require Medicare Advantage plans to submit accurate billing data and to promptly return any identified overpayments.
The action came amid longstanding government investigations and audits revealing systematic overbilling in Medicare Advantage plans. The $342 million settlement emerged as a rare successful effort by CMS to recoup substantial funds from a Medicare Advantage health plan in response to these issues.
Key Facts
Medicare Advantage plans cover over 35 million Americans—around 55% of Medicare beneficiaries—and often provide additional benefits not included in traditional Medicare. Elevance Health’s repayment follows audits estimating the overcharges. The company’s current estimated “potential exposure” in ongoing litigation with the Department of Justice is approximately $935 million.
The allegations stem from CMS audits and a False Claims Act lawsuit filed by the DOJ in 2020, which remains pending. Whistleblower lawsuits alleging inflated billing practices have also targeted various Medicare Advantage insurers, including a $556 million settlement by Kaiser Permanente earlier in 2023 for similar claims.
Experts note that Medicare Advantage payments are adjusted based on patient health status, but plans may only bill for conditions properly supported by medical records. Research cited in official documents estimates Medicare overpays insurers by billions annually due to coding inaccuracies favoring higher payments.
What This Means
Elevance Health’s significant repayment may signal a shift in CMS’s willingness and ability to enforce billing accuracy within Medicare Advantage plans, an area where previous regulatory efforts have faced resistance and limited recovery of funds. The settlement shows CMS is prepared to leverage enrollment restrictions as a tool to pressure large insurers to comply with billing rules, potentially incentivizing broader industry reforms.
For Medicare beneficiaries and taxpayers, this development could mean improved oversight of Medicare funds and steps toward reducing improper expenditures that inflate government healthcare costs. However, experts caution that this payment, while substantial, accounts for only a fraction of overall Medicare Advantage revenue and overpayments. Meaningful change will require comprehensive enforcement across multiple insurers to address systemic overbilling.
The move also underscores ongoing tensions between health plans and federal regulators, with Elevance disputing wrongdoing and characterizing CMS’s enforcement as “unprecedented.” How this dynamic will evolve remains a key question for future policy and oversight strategies.
Background
Medicare Advantage programs have grown rapidly, offering privately managed healthcare to most Medicare recipients, and their payment structures incentivize documenting patient illness severity. This system has faced continuous scrutiny for encouraging upcoding—where insurers report patients as sicker than clinical evidence supports to receive higher reimbursements.
Past CMS attempts to tighten billing rules have often been stymied by industry opposition, including the 2014 withdrawal of proposed anti-overbilling regulations. Historically, CMS audits have identified substantial overpayments, but recovery efforts have been limited in scale until recently.
Analysis
David Lipschutz of the Center for Medicare Advocacy characterized the settlement as unprecedented, noting insurers typically delay repayment for years. Brown University’s David Meyers described the payment as a “step in the right direction” toward industry accountability. Similarly, Brookings Institution researcher Matthew Fiedler acknowledged CMS’s enforcement might mark progress, though he emphasized that single-company settlements are insufficient to fully address chronic overpayment issues.
Richard Kronick, former federal health policy official, noted the payment reflects agency “muscle flexing” that could affect future regulatory compliance but pointed out it still represents a small portion of the insurer’s total federal revenues.
What Remains Unclear
It is not yet confirmed whether the settlement resolves the threat of CMS banning Elevance from enrolling new members. The pending DOJ lawsuit remains unresolved, and it is unclear if other Medicare Advantage insurers will face similar enforcement actions. The broader impact on Medicare Advantage payment practices and audit recoveries in the short term is still uncertain.
What Comes Next
CMS’s move to leverage enrollment restrictions signals a possible new enforcement strategy, but substantial follow-up actions or policy changes have not yet been announced. The outcome of the ongoing DOJ lawsuit against Elevance Health may provide additional clarity on the company’s billing practices and government response.
Sources
This article is based on reporting and publicly available information from the following sources:
Read more Health & Public Health stories on Goka World News.